MT
Matinas BioPharma Holdings, Inc.
MTNB · AMEX
$0.16 -15.83% (-$0.03)
1M -27.99%
Market Cap $1.04M
P/E Ratio -
Div. Yield -
ROE 181.46%
Bulios Fair Price
$0.19
17.6% upside
Trenutna cena
$0.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MTNB trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.58x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 49.10%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 214.22%
ROIC 323.22%
Debt
76 /100
Low Current ratio 0.85x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
13 /100
Unstable EPS volatility 68.38%
Profitable years 0
Beta 1.70x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MTNB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jerome D. Jabbour
Employees
2
Headquarters
Bedminster
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report